Cargando…
High-Dose Methylprednisolone Pulses for 3 Days vs. Low-Dose Dexamethasone for 10 Days in Severe, Non-Critical COVID-19: A Retrospective Propensity Score Matched Analysis
Corticosteroids are largely recommended in patients with severe COVID-19. However, evidence to support high-dose methylprednisolone (MP) pulses is not as robust as that demonstrated for low-dose dexamethasone (DXM) in the RECOVERY trial. This is a retrospective cohort study on severe, non-critically...
Autores principales: | Mora-Luján, José María, Tuells, Manel, Montero, Abelardo, Formiga, Francesc, Homs, Narcís A., Albà-Albalate, Joan, Corbella, Xavier, Rubio-Rivas, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509662/ https://www.ncbi.nlm.nih.gov/pubmed/34640481 http://dx.doi.org/10.3390/jcm10194465 |
Ejemplares similares
-
Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
por: Pinzón, Miguel Alejandro, et al.
Publicado: (2021) -
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone
por: Russo, Alessandro, et al.
Publicado: (2022) -
Evidence of functional declining and global comorbidity measured at baseline proved to be the strongest predictors for long-term death in elderly community residents aged 85 years: a 5-year follow-up evaluation, the OCTABAIX study
por: Formiga, Francesc, et al.
Publicado: (2016) -
Doses of Calomel in Days of Yore
Publicado: (1826) -
Antiemetic efficacy of single-dose palonosetron and dexamethasone in patients receiving multiple cycles of multiple day-based chemotherapy
por: Lorusso, Vito, et al.
Publicado: (2012)